AlphaClone CEO Maz Jadallah and FBN’s Charlie Gasparino on activist Bill Ackman’s decision to team up with Valeant for a bid for Allergan.
Connect with us.
Is the S&P 500 a Value Trap in 2019?
CNBC: Invest Like a Whale
Fox Business News: Invest Like a Billionaire
BNN: Hedge Funds Underperforming: Who’s Investing in Them & Why?
Why Smart Alpha is the Cure for Passive Management Problems
AlphaClone Expands, Raises $2.25 Million Financing Led by Operative Capital
It might not have been obvious, but you're now leaving the AlphaClone.com site and going to the AlphaCloneETFs.com site, which provides more information on our ETF products. The government really wanted us to tell you that.